Related Content
May 31, 2018 — Two-year outcome data from the BIO-RESORT randomized controlled trial were presented in a late-breaking ...
April 12, 2018 — Biotronik U.S. and Aziyo announced a strategic agreement allowing Biotronik to distribute Aziyo's ...
November 3, 2017 — Biotronik's Orsiro drug-eluting stent (DES) demonstrated high long-term safety and clinical ...
September 22, 2017 — Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy ...
September 1, 2017 — Biotronik recently announced data from the BIOFLOW-V randomized trial comparing Orsiro and Xience ...
August 21, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of ...
July 21, 2017 — Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX ...
July 13, 2017 — Experts in heart failure management gathered in June to discuss varying scientific evidence in their ...
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve ...
May 23, 2017 – Results now published in the European Heart Journal show Biotronik Home Monitoring reduces the risk of ...